Please enable JavaScript to continue using this application.

Compare $RVTY vs $TECH | Chartloom

Compare

$RVTY vs $TECH

Revvity Inc · Bio-Techne Corp

RVTY

Revvity Inc

TECH

Bio-Techne Corp

Compare $RVTY vs $TECH

Comparing Revvity Inc and Bio-Techne Corp

RVTYRevvity Inc

TECHBio-Techne Corp

RVTYRevvity Inc

Market cap

$17.20B

P/E (TTM)

72.45x

Forward P/E (NTM)

26.16x

Forward P/S (NTM)

5.62x

Rev growth (TTM)

4.1%

YTD performance

57.1%

52W performance

68.0%

FCF yield

3.2%

TECHBio-Techne Corp

Market cap

$11.29B

P/E (TTM)

62.64x

Forward P/E (NTM)

34.64x

Forward P/S (NTM)

8.77x

Rev growth (TTM)

-0.4%

YTD performance

21.5%

52W performance

19.6%

FCF yield

2.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

RVTY

TECH

Detailed metrics comparison

RVTY

Revvity Inc

TECH

Bio-Techne Corp

Market Cap

RVTY$17.20B

TECH$11.29B

Enterprise Value

RVTY$19.38B

TECH$11.23B

Price

RVTY$154.18

TECH$72.46

P/E Ratio

RVTY72.45x

TECH62.64x

P/S Ratio

RVTY5.91x

TECH9.29x

EV/Sales

RVTY6.66x

TECH9.24x

EV/EBITDA

RVTY23.79x

TECH28.63x

P/B Ratio

RVTY2.34x

TECH5.39x

P/FCF Ratio

RVTY30.82x

TECH42.89x

EV/FCF

RVTY34.73x

TECH42.65x

PEG Ratio

RVTY7.30x

TECH9.81x

Forward P/E (NTM)

RVTY26.16x

TECH34.64x

Forward P/S (NTM)

RVTY5.62x

TECH8.77x

Revenue (TTM)

RVTY$2.91B

TECH$1.22B

Revenue Growth (YoY)

RVTY4.1%

TECH-0.4%

Forward Rev Growth

RVTY5.2%

TECH9.8%

Gross Margin (TTM)

RVTY55.0%

TECH66.2%

Operating Margin (TTM)

RVTY12.3%

TECH20.7%

EBITDA Margin (TTM)

RVTY28.0%

TECH31.6%

Net Margin (TTM)

RVTY8.2%

TECH15.0%

FCF Margin (TTM)

RVTY19.2%

TECH21.7%

Net Income (TTM)

RVTY$238M

TECH$182M

FCF (TTM)

RVTY$558M

TECH$263M

EPS (TTM)

RVTY$2.13

TECH$1.16

ROE (TTM)

RVTY3.3%

TECH8.9%

ROA (TTM)

RVTY2.0%

TECH7.1%

ROIC (TTM)

RVTY2.3%

TECH8.0%

Cash

RVTY$1.02B

TECH$265M

Debt

RVTY$3.21B

TECH$200M

Net Cash/Debt

RVTY$-2.18B

TECH$65M

Current Ratio (TTM)

RVTY1.80x

TECH4.55x

Quick Ratio (TTM)

RVTY1.50x

TECH3.35x

Debt/Equity (TTM)

RVTY0.44x

TECH0.09x

Debt/Assets (TTM)

RVTY0.0%

TECH0.0%

Interest Coverage (TTM)

RVTYN/A

TECHN/A

Net Debt/EBITDA (TTM)

RVTY0.00x

TECH0.00x

Beta

RVTY1.09

TECH1.29

52W Performance

RVTY68.0%

TECH19.6%

YTD Performance

RVTY57.1%

TECH21.5%

% from 52W High

RVTY-7.3%

TECH-0.3%

% from 52W Low

RVTY89.8%

TECH67.7%

Asset Turnover (TTM)

RVTY0.24x

TECH0.48x

FCF Yield (TTM)

RVTY3.2%

TECH2.3%

Earnings Yield (TTM)

RVTY1.4%

TECH1.6%

Dividend Yield (TTM)

RVTY0.2%

TECH0.4%

Rule of 40

RVTY23.2

TECH21.3

EV/GP/RG

RVTY2.33

TECH2.28

Ticker research

View RVTY research View TECH research

Metric	RVTY Revvity Inc	TECH Bio-Techne Corp
Market & Valuation
Market Cap	$17.20B	$11.29B
Enterprise Value	$19.38B	$11.23B
Price	$154.18	$72.46
P/E Ratio	72.45x	62.64x
P/S Ratio	5.91x	9.29x
EV/Sales	6.66x	9.24x
EV/EBITDA	23.79x	28.63x
P/B Ratio	2.34x	5.39x
P/FCF Ratio	30.82x	42.89x
EV/FCF	34.73x	42.65x
PEG Ratio	7.30x	9.81x
Forward P/E (NTM)	26.16x	34.64x
Forward P/S (NTM)	5.62x	8.77x
Revenue & Growth
Revenue (TTM)	$2.91B	$1.22B
Revenue Growth (YoY)	4.1%	-0.4%
Forward Rev Growth	5.2%	9.8%
Profitability
Gross Margin (TTM)	55.0%	66.2%
Operating Margin (TTM)	12.3%	20.7%
EBITDA Margin (TTM)	28.0%	31.6%
Net Margin (TTM)	8.2%	15.0%
FCF Margin (TTM)	19.2%	21.7%
Net Income (TTM)	$238M	$182M
FCF (TTM)	$558M	$263M
EPS (TTM)	$2.13	$1.16
ROE (TTM)	3.3%	8.9%
ROA (TTM)	2.0%	7.1%
ROIC (TTM)	2.3%	8.0%
Financial Health
Cash	$1.02B	$265M
Debt	$3.21B	$200M
Net Cash/Debt	$-2.18B	$65M
Current Ratio (TTM)	1.80x	4.55x
Quick Ratio (TTM)	1.50x	3.35x
Debt/Equity (TTM)	0.44x	0.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.09	1.29
52W Performance	68.0%	19.6%
YTD Performance	57.1%	21.5%
% from 52W High	-7.3%	-0.3%
% from 52W Low	89.8%	67.7%
Efficiency & Yields
Asset Turnover (TTM)	0.24x	0.48x
FCF Yield (TTM)	3.2%	2.3%
Earnings Yield (TTM)	1.4%	1.6%
Dividend Yield (TTM)	0.2%	0.4%
Other
Rule of 40	23.2	21.3
EV/GP/RG	2.33	2.28
Ticker research	View RVTY research	View TECH research

Valuation

P/E Ratio

TECH

62.64x

RVTY

72.45x

P/S Ratio

RVTY

5.91x

TECH

9.29x

EV/FCF

RVTY

34.73x

TECH

42.65x

Growth & revenue

Revenue Growth TTM

RVTY

4.1%

TECH

-0.4%

Forward Revenue Growth

TECH

9.8%

RVTY

5.2%

Profitability & performance

Gross Margin

TECH

66.2%

RVTY

55.0%

ROE

TECH

8.9%

RVTY

3.3%

FCF Yield %

RVTY

3.2%

TECH

2.3%

52-Week Performance

RVTY

68.0%

TECH

19.6%

Detailed metrics comparison

RVTY

Revvity Inc

TECH

Bio-Techne Corp

Market Cap

RVTY$17.20B

TECH$11.29B

Enterprise Value

RVTY$19.38B

TECH$11.23B

Price

RVTY$154.18

TECH$72.46

P/E Ratio

RVTY72.45x

TECH62.64x

P/S Ratio

RVTY5.91x

TECH9.29x

EV/Sales

RVTY6.66x

TECH9.24x

EV/EBITDA

RVTY23.79x

TECH28.63x

P/B Ratio

RVTY2.34x

TECH5.39x

P/FCF Ratio

RVTY30.82x

TECH42.89x

EV/FCF

RVTY34.73x

TECH42.65x

PEG Ratio

RVTY7.30x

TECH9.81x

Forward P/E (NTM)

RVTY26.16x

TECH34.64x

Forward P/S (NTM)

RVTY5.62x

TECH8.77x

Revenue (TTM)

RVTY$2.91B

TECH$1.22B

Revenue Growth (YoY)

RVTY4.1%

TECH-0.4%

Forward Rev Growth

RVTY5.2%

TECH9.8%

Gross Margin (TTM)

RVTY55.0%

TECH66.2%

Operating Margin (TTM)

RVTY12.3%

TECH20.7%

EBITDA Margin (TTM)

RVTY28.0%

TECH31.6%

Net Margin (TTM)

RVTY8.2%

TECH15.0%

FCF Margin (TTM)

RVTY19.2%

TECH21.7%

Net Income (TTM)

RVTY$238M

TECH$182M

FCF (TTM)

RVTY$558M

TECH$263M

EPS (TTM)

RVTY$2.13

TECH$1.16

ROE (TTM)

RVTY3.3%

TECH8.9%

ROA (TTM)

RVTY2.0%

TECH7.1%

ROIC (TTM)

RVTY2.3%

TECH8.0%

Cash

RVTY$1.02B

TECH$265M

Debt

RVTY$3.21B

TECH$200M

Net Cash/Debt

RVTY$-2.18B

TECH$65M

Current Ratio (TTM)

RVTY1.80x

TECH4.55x

Quick Ratio (TTM)

RVTY1.50x

TECH3.35x

Debt/Equity (TTM)

RVTY0.44x

TECH0.09x

Debt/Assets (TTM)

RVTY0.0%

TECH0.0%

Interest Coverage (TTM)

RVTYN/A

TECHN/A

Net Debt/EBITDA (TTM)

RVTY0.00x

TECH0.00x

Beta

RVTY1.09

TECH1.29

52W Performance

RVTY68.0%

TECH19.6%

YTD Performance

RVTY57.1%

TECH21.5%

% from 52W High

RVTY-7.3%

TECH-0.3%

% from 52W Low

RVTY89.8%

TECH67.7%

Asset Turnover (TTM)

RVTY0.24x

TECH0.48x

FCF Yield (TTM)

RVTY3.2%

TECH2.3%

Earnings Yield (TTM)

RVTY1.4%

TECH1.6%

Dividend Yield (TTM)

RVTY0.2%

TECH0.4%

Rule of 40

RVTY23.2

TECH21.3

EV/GP/RG

RVTY2.33

TECH2.28

Ticker research

View RVTY research View TECH research

Metric	RVTY Revvity Inc	TECH Bio-Techne Corp
Market & Valuation
Market Cap	$17.20B	$11.29B
Enterprise Value	$19.38B	$11.23B
Price	$154.18	$72.46
P/E Ratio	72.45x	62.64x
P/S Ratio	5.91x	9.29x
EV/Sales	6.66x	9.24x
EV/EBITDA	23.79x	28.63x
P/B Ratio	2.34x	5.39x
P/FCF Ratio	30.82x	42.89x
EV/FCF	34.73x	42.65x
PEG Ratio	7.30x	9.81x
Forward P/E (NTM)	26.16x	34.64x
Forward P/S (NTM)	5.62x	8.77x
Revenue & Growth
Revenue (TTM)	$2.91B	$1.22B
Revenue Growth (YoY)	4.1%	-0.4%
Forward Rev Growth	5.2%	9.8%
Profitability
Gross Margin (TTM)	55.0%	66.2%
Operating Margin (TTM)	12.3%	20.7%
EBITDA Margin (TTM)	28.0%	31.6%
Net Margin (TTM)	8.2%	15.0%
FCF Margin (TTM)	19.2%	21.7%
Net Income (TTM)	$238M	$182M
FCF (TTM)	$558M	$263M
EPS (TTM)	$2.13	$1.16
ROE (TTM)	3.3%	8.9%
ROA (TTM)	2.0%	7.1%
ROIC (TTM)	2.3%	8.0%
Financial Health
Cash	$1.02B	$265M
Debt	$3.21B	$200M
Net Cash/Debt	$-2.18B	$65M
Current Ratio (TTM)	1.80x	4.55x
Quick Ratio (TTM)	1.50x	3.35x
Debt/Equity (TTM)	0.44x	0.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.09	1.29
52W Performance	68.0%	19.6%
YTD Performance	57.1%	21.5%
% from 52W High	-7.3%	-0.3%
% from 52W Low	89.8%	67.7%
Efficiency & Yields
Asset Turnover (TTM)	0.24x	0.48x
FCF Yield (TTM)	3.2%	2.3%
Earnings Yield (TTM)	1.4%	1.6%
Dividend Yield (TTM)	0.2%	0.4%
Other
Rule of 40	23.2	21.3
EV/GP/RG	2.33	2.28
Ticker research	View RVTY research	View TECH research